Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.
$3.98
As of 03/01/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.